Detargeting Lentiviral-Mediated CFTR Expression in Airway Basal Cells Using miR-106b.

Area of Science:

• * Molecular Biology
• * Gene Therapy
• * Stem Cell Biology

Background:

• * Cystic fibrosis (CF) cell-based therapies aim to restore CF transmembrane conductance regulator (CFTR) function.
• * Lentiviral vectors are being explored for gene delivery to airway basal stem cells.
• * Basal stem cells typically lack CFTR expression, suggesting a need to regulate transgene expression.

Purpose of the Study:

• * To investigate the role of miR-106b in airway basal cell differentiation.
• * To develop lentiviral vectors for detargeting CFTR expression in basal stem cells.
• * To assess the impact of miR-106b-mediated regulation on CFTR function.

Main Methods:

• * Development of lentiviral vectors incorporating miR-106b target sequences (miRT).
• * Creation of a 293T-B2 cell line to improve viral production.
• * Assessment of reporter gene and CFTR expression in basal cells, air-liquid interface, and organoid cultures.

Main Results:

• * miR-106b vectors successfully detargeted reporter gene expression in proliferating basal cells and differentiated cells.
• * The CFTR-miRT vector resulted in significantly reduced CFTR-mediated current compared to non-targeted vectors.
• * miR-106b is expressed in airway cell types crucial for CFTR anion transport.

Conclusions:

• * miR-106b is a key regulator in airway basal cells, decreasing as they differentiate.
• * Detargeting CFTR expression in basal cells via miR-106b may affect overall airway epithelium function.
• * Further research is needed to optimize lentiviral vector design for CFTR gene therapy.